APA (7th ed.) Citation

Zhang, Z., Li, J., Zheng, J., Liang, Y., Ma, L., & Su, L. (2025). Tirzepatide safety in type 2 diabetes: A disproportionality analysis of adverse events using the FDA FAERS database. Bioscientifica.

Chicago Style (17th ed.) Citation

Zhang, Zhenpo, Jiangxiong Li, Jingping Zheng, Yankun Liang, Lin Ma, and Ling Su. Tirzepatide Safety in Type 2 Diabetes: A Disproportionality Analysis of Adverse Events Using the FDA FAERS Database. Bioscientifica, 2025.

MLA (9th ed.) Citation

Zhang, Zhenpo, et al. Tirzepatide Safety in Type 2 Diabetes: A Disproportionality Analysis of Adverse Events Using the FDA FAERS Database. Bioscientifica, 2025.